## LULU: lululemon athletica inc. - XLY: Consumer Cyclical

### Executive Summary

VALUE thesis: PEG 0.90 indicates fundamental undervaluation. Quality metrics strong (ROE 42%, ROA 22%). Consistent execution (4/4 quarters beat estimates).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($170.86)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. 3 Cyber Monday Stock Deals: More Than 50% Off in 2025**
- Source: The Globe and Mail | 20251201T140700 | Neutral | Relevance: 99%
- This article highlights three stocks – Lululemon, Cava, and Freshpet – that have lost over 50% of their value in 2025, presenting them as potential Cyber Monday deals. It provides an in-depth look at each company's recent performance, challenges, and future prospects, suggesting they could be turnaround stories. The analysis covers financial metrics, growth drivers, and market positioning for each company.

**2. Lululemon Athletica Inc (LULU) Stock on November 30, 2025: Deep‑Value Debate, Institutional Buying, and Key Risks Before Q3 Earnings**
- Source: ts2.tech | 20251130T125210 | Neutral | Relevance: 99%
- Lululemon (LULU) stock is experiencing a "deep-value debate" as it heads into Q3 earnings, with institutional investors rotating positions after a significant sell-off. The article details institutional buying, analyst sentiments split between "buy the dip" and "strong sell," and outlines key risks including product missteps, declining U.S. demand, and tariff impacts. Investors are closely watching the upcoming December 11, 2025, Q3 earnings call for updates on U.S. sales, margins, and international growth.

**3. Russell Investments Group Ltd. Trims Stake in lululemon athletica inc. $LULU**
- Source: MarketBeat | 20251201T112158 | Neutral | Relevance: 98%
- Russell Investments Group Ltd. reduced its stake in lululemon athletica inc. by 21.7% in Q2 2025, selling 27,321 shares and retaining 98,646 shares valued at $23.4 million. This move aligns with a broader trend of analysts trimming price targets and issuing "Hold" ratings for LULU, despite the company beating Q2 EPS estimates and issuing positive FY2025 guidance. The stock's performance and institutional investor activity indicate a cautious outlook from some major players, while others like Migdal Insurance & Financial Holdings Ltd. significantly increased their holdings.

**4. Grandeur Peak Global Advisors LLC Sells 63,856 Shares of lululemon athletica inc. $LULU**
- Source: MarketBeat | 20251201T093841 | Neutral | Relevance: 98%
-  Grandeur Peak Global Advisors LLC significantly reduced its stake in lululemon athletica (NASDAQ:LULU) by 42.8% in Q2, selling 63,856 shares and now holding 85,346 shares valued at over $20 million. This comes as Lululemon reported Q2 earnings per share of $3.10, beating estimates, but revenue slightly missed expectations, and the company set lower-than-analyst-consensus FY2025 EPS guidance. The stock has seen mixed institutional activity and recent analyst downgrades, reflecting a cautious outlook despite strong Q2 EPS performance.

**5. River Road Asset Management LLC Buys 107,013 Shares of lululemon athletica inc. $LULU**
- Source: MarketBeat | 20251202T122223 | Neutral | Relevance: 98%
- River Road Asset Management LLC significantly increased its stake in lululemon athletica inc. by purchasing 107,013 additional shares in Q2, bringing their total holdings to 198,578 shares valued at approximately $47.2 million. The athletic apparel retailer's stock is currently rated "Hold" by analysts with an average target price of $227.68, while the company reported mixed Q2 earnings, beating EPS estimates but slightly missing revenue expectations. Institutional investors collectively own 85.20% of lululemon athletica's stock.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 2)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-10 | Guggenheim | $0 | $0 | 0% |
| 2025-12-08 | Telsey Advisory | $200 | $200 | 0% |
| 2025-11-25 | BTIG | $303 | $303 | 0% |
| 2025-11-18 | Goldman Sachs | $180 | $200 | -10% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-10 | Guggenheim | init | Neutral |
| 2025-12-08 | Telsey Advisory | main | Market Perform |
| 2025-11-25 | BTIG | reit | Buy |
| 2025-11-18 | Goldman Sachs | main | Neutral |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 1 ($0.11M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 40.1% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 12.1% (+3.9%)
- Blackrock Inc.: 8.8% (-0.9%)
- State Street Corpora: 4.1% (-1.1%)
- FMR, LLC: 3.6% (-65.8%)
- Geode Capital Manage: 2.6% (+0.6%)

### Key Risks

1. Elevated short interest (8.0%): bears positioning against stock.
2. Long-term trend broken: trading 23.4% below SMA200.
3. Falling knife pattern: rapid decline without stabilization, catch risk elevated.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 0.90 indicates undervaluation relative to growth. Forward P/E 14.1x stretched relative to 1% growth. Quality metrics strong (ROE 42%, ROA 22%, margin 16%). Balance sheet: strong liquidity (2.3x). Analyst sentiment negative (2 target cuts vs 0 raises). Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $22.5B |
| Beta | 1.01 |
| 52W Range | $159.25 - $423.32 |
| Short Interest | 8.0% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.90 |
| Forward P/E | 14.1 |
| Current P/E | 14.2 |
| YoY Growth | 0.9% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 6.1% to 5.0% (-1.0% in 5 days), indicating relative weakness vs NASDAQ. Currently in lower STRENGTH zone (4.0-10.0%), cross-sectional ranking at 90th percentile. MRS_5 (-0.3%) diverging from MRS_20 - short-term weakness emerging. AM_20 at 6.8% shows strong absolute momentum above own 20MA. Outperforming sector by 5.3pp, stock-specific strength. Below SMA200 (0.77x), long-term trend not supportive. MACD histogram positive (2.14), confirming momentum.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 5.02% (CS: 91) | Strong |
| RSI_14 | 62.2 | Neutral |
| MACD Histogram | 2.14 | Bullish |
| vs SMA20 | 1.068x | Above |
| vs SMA50 | 1.057x | Above |
| vs SMA200 | 0.766x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $182.40
- **Stop Loss:** $170.86 (6.3% risk)
- **Target:** $205.48 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 86
- **Position Value:** $15,686.40
- **Portfolio %:** 15.69%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate improvement trajectory. VIX compression from 20.5 to 16.6 over 5 days signals declining fear, while 47% breadth shows narrow but recovering participation. Fed meeting in 6 days creates near-term uncertainty, but AI sector momentum and improving technical setups support selective positioning.*

### Earnings

**Next:** 2025-12-11 (Est: $2.72)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.85 | $3.10 | +8.7% |
| 2025Q2 | $2.59 | $2.60 | +0.4% |
| 2025Q1 | $5.87 | $6.14 | +4.6% |
| 2024Q4 | $2.72 | $2.87 | +5.5% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*